Antimicrobial Agents Practice Questions

Q: What is the drug of choice for malaria during pregnancy?

Chloroquine. **Explanation:** The management of malaria in pregnancy requires a balance between therapeutic efficacy and fetal safety. **Chloroquine** is the drug of choice for the treatment of uncomplicated malaria (specifically *P. vivax* and sensitive *P. falciparum*) during all trimesters of pregnancy. It is considered safe, non-teratogenic, and has a well-established safety profile for both the mother and the fetus. **Analysis of Options:** * **Chloroquine (Correct):** It is the gold standard for sensitive strains in pregnancy. For chloroquine-resistant *P. falciparum*, ACT (Artemisinin-based Combination Therapy) is now recommended by the WHO across all trimesters, but Chloroquine remains the classic answer for general sensitivity. * **Quinine:** Historically used for severe malaria or resistant cases in the first trimester. However, it is associated with severe hypoglycemia and is no longer the first-line choice if safer alternatives are available. * **Primaquine (Contraindicated):** This is the most important "wrong" option to remember. Primaquine causes **hemolysis in the fetus** (due to potential G6PD deficiency) and can lead to intrauterine death. It is strictly contraindicated throughout pregnancy. * **Mepacrine:** An older antimalarial rarely used today due to significant toxicity (psychosis, yellow skin discoloration) and is not a standard of care in pregnancy. **High-Yield Clinical Pearls for NEET-PG:** * **Radical Cure:** Since Primaquine is contraindicated, radical cure for *P. vivax* (to kill hypnozoites) must be **deferred** until after delivery and after checking the infant's G6PD status if breastfeeding. * **Severe Malaria in Pregnancy:** IV Artesunate is the drug of choice for severe malaria in all trimesters. * **Chemoprophylaxis:** For pregnant travelers to endemic areas, Chloroquine is used where sensitive; Proguanil is an alternative.

Q: In the treatment of Hepatitis C, interferon is combined with which drug?

Ribavarin. **Explanation:** **Why Ribavirin is Correct:** The traditional standard of care for chronic Hepatitis C (HCV) infection involves the combination of **Pegylated Interferon-alpha and Ribavirin**. Ribavirin is a guanosine analogue that exerts antiviral effects through multiple mechanisms, including inhibition of RNA-dependent RNA polymerase, induction of lethal mutagenesis (error catastrophe), and modulation of the host immune response. When used alone, Ribavirin is ineffective at clearing HCV; however, it acts **synergistically** with Interferon to significantly increase the Sustained Virological Response (SVR) rate and prevent relapses. **Why Other Options are Incorrect:** * **Acyclovir:** A guanosine analogue used primarily for Herpes Simplex Virus (HSV) and Varicella-Zoster Virus (VZV). It requires viral thymidine kinase for activation, which HCV lacks. * **Lamivudine:** A nucleoside reverse transcriptase inhibitor (NRTI) used in the treatment of HIV and **Hepatitis B (HBV)**, but it has no clinical efficacy against HCV. * **Indinavir:** A Protease Inhibitor used specifically in the HAART regimen for **HIV**. While newer HCV drugs (like Simeprevir) are also protease inhibitors, Indinavir does not target the HCV NS3/4A protease. **High-Yield Clinical Pearls for NEET-PG:** * **Ribavirin Toxicity:** The most characteristic side effect is **dose-dependent hemolytic anemia**. It is also highly **teratogenic** (contraindicated in pregnancy; effective contraception is required for 6 months post-treatment). * **Interferon Side Effects:** "Flu-like symptoms" (fever, chills, myalgia) and neuropsychiatric issues (severe depression/suicidal ideation). * **Current Trend:** While Interferon + Ribavirin was the gold standard, it has largely been replaced by **Direct-Acting Antivirals (DAAs)** like Sofosbuvir and Ledipasvir, which are interferon-free and have higher cure rates.

Q: Penicillin is effective against which of the following organisms?

All of the above. Penicillin G (Benzylpenicillin) remains a cornerstone of antimicrobial therapy, primarily targeting Gram-positive cocci and specific Gram-negative organisms. Its mechanism involves inhibiting bacterial cell wall synthesis by binding to **Penicillin-Binding Proteins (PBPs)**, preventing the cross-linking of peptidoglycan [3]. **Why "All of the above" is correct:** * **Treponema pallidum (Option C):** Penicillin G is the **drug of choice** for all stages of Syphilis. *T. pallidum* has remarkably maintained its sensitivity to penicillin over decades, with no significant resistance reported. * **Neisseria meningitidis (Option A):** While Ceftriaxone is often used empirically for meningitis, Penicillin G remains highly effective against sensitive strains of *N. meningitidis* and is a preferred narrow-spectrum agent once sensitivity is confirmed [1]. * **Neisseria gonorrhoeae (Option B):** Historically, penicillin was the first-line treatment for Gonorrhea. Although high-level resistance (PPNG - Penicillinase-producing *N. gonorrhoeae*) has made it obsolete for empirical treatment in many regions, the organism is biologically susceptible to the drug's mechanism [1]. **NEET-PG High-Yield Pearls:** 1. **Drug of Choice (DOC):** Benzathine Penicillin G is the DOC for **Syphilis** and **Rheumatic fever prophylaxis**. 2. **Jarisch-Herxheimer Reaction:** A classic side effect seen during the treatment of Syphilis with penicillin due to the release of endotoxins from dying spirochetes. 3. **Resistance:** Most *Staphylococci* are now resistant to Penicillin G due to **beta-lactamase (penicillinase)** production [2]. 4. **Excretion:** Penicillin is rapidly excreted by the kidneys via **tubular secretion** (90%); this process can be inhibited by **Probenecid** to prolong its action.

Q: Tetracycline is a broad-spectrum antibiotic. What is the primary mechanism of resistance developed against this drug?

Efflux pump mechanism. ### Explanation **Correct Option: B. Efflux pump mechanism** Tetracyclines act by inhibiting protein synthesis through reversible binding to the **30S ribosomal subunit**. The most common and clinically significant mechanism of resistance is the **active efflux** of the drug out of the bacterial cell. This is mediated by plasmid-encoded transport proteins (e.g., **TetA**), which pump the drug out faster than it can diffuse in, preventing it from reaching inhibitory concentrations at the ribosome. Another important mechanism is **ribosomal protection**, where proteins (e.g., TetM) interfere with tetracycline binding. **Analysis of Incorrect Options:** * **A. Enzymatic inactivation:** While common for Penicillins (Beta-lactamases) and Aminoglycosides (acetyltransferases), it is a rare mechanism for tetracyclines (seen only in some *Bacteroides* species). * **C. Alteration of binding site:** This is the primary mechanism for **Macrolides** (methylation of 23S rRNA) and **Fluoroquinolones** (DNA gyrase mutations), but not the predominant mechanism for tetracyclines. * **D. Absence of metabolic pathway:** This refers to **intrinsic resistance** (e.g., anaerobic bacteria being resistant to aminoglycosides because they lack the oxygen-dependent transport required for drug entry). **NEET-PG High-Yield Pearls:** * **Tigecycline:** A glycylcycline developed specifically to overcome efflux-mediated resistance; it is effective against many tetracycline-resistant organisms (except *Proteus* and *Pseudomonas*). * **Drug of Choice (DOC):** Tetracyclines (specifically Doxycycline) remain the DOC for Rickettsial infections, Chlamydia, Cholera, and Brucellosis. * **Adverse Effects:** Look for "Fanconi Syndrome" (outdated/expired tetracyclines) and "Phototoxicity" (most common with Demeclocycline).

Q: Which anti-tuberculosis drug is not toxic to the liver?

Streptomycin. **Explanation:** The correct answer is **Streptomycin** because it is an aminoglycoside, a class of drugs primarily excreted unchanged by the kidneys. Unlike most first-line anti-tuberculosis (ATT) drugs, streptomycin does not undergo hepatic metabolism and therefore lacks hepatotoxic potential. **Why the other options are incorrect:** * **Isoniazid (INH):** It is a major cause of drug-induced hepatitis. It is metabolized via acetylation; "slow acetylators" are at a higher risk of toxicity. It can also cause a transient rise in transaminases. * **Rifampicin:** It is hepatotoxic and typically causes a cholestatic pattern of jaundice. It is also a potent microsomal enzyme inducer, which can increase the hepatotoxicity of isoniazid when used in combination. * **Pyrazinamide:** This is considered the **most hepatotoxic** drug among the first-line ATT agents. It can cause severe liver injury and is often the first drug to be discontinued if jaundice occurs. **NEET-PG High-Yield Pearls:** 1. **Hepatotoxicity Ranking:** Pyrazinamide > Isoniazid > Rifampicin. Ethambutol and Streptomycin are the two first-line drugs that are **not** hepatotoxic. 2. **Streptomycin Toxicity:** Its primary dose-limiting toxicities are **ototoxicity** (vestibular > auditory) and **nephrotoxicity**. It is also contraindicated in pregnancy due to the risk of fetal eighth cranial nerve damage. 3. **Visual Side Effects:** If a question asks about visual disturbances (optic neuritis) instead of liver toxicity, the answer is **Ethambutol**. 4. **Management:** In patients with pre-existing liver disease, a "liver-friendly" regimen often includes Streptomycin and Ethambutol.

Q: Which drug can cause complete histopathological resolution in patients with hepatitis B?

Entecavir. **Explanation:** **Entecavir** is a potent deoxyguanosine nucleoside analog that inhibits Hepatitis B Virus (HBV) polymerase at three stages: priming, reverse transcription, and synthesis of the positive-strand DNA. It is considered a first-line treatment for chronic HBV due to its high genetic barrier to resistance and superior efficacy. Clinical studies have demonstrated that long-term therapy with Entecavir leads to significant **histological improvement**, including the reduction of necroinflammatory activity and, crucially, the **reversal of fibrosis and cirrhosis** (complete histopathological resolution) in a majority of patients. **Why other options are incorrect:** * **Cyclosporin:** This is a calcineurin inhibitor used as an immunosuppressant. While it has some *in vitro* activity against certain viruses by inhibiting cyclophilins, it is not used to treat HBV and can actually exacerbate viral replication by suppressing the host immune response. * **Ribavirin:** This is a guanosine analog used primarily for Hepatitis C (in combination with Interferon or DAAs) and RSV. It has no significant clinical efficacy against the Hepatitis B virus. **High-Yield Clinical Pearls for NEET-PG:** * **First-line HBV drugs:** Entecavir and Tenofovir (TDF/TAF) are preferred due to low resistance rates. * **Mechanism:** Entecavir requires intracellular phosphorylation to the active triphosphate form. * **Safety:** Entecavir is generally well-tolerated but requires dose adjustment in renal impairment. Unlike Tenofovir, it is not associated with significant bone or renal toxicity. * **Lamivudine Resistance:** Patients with prior Lamivudine resistance have a higher risk of developing resistance to Entecavir.

Q: Which drug does NOT inhibit nucleic acid synthesis?

Linezolid. ### Explanation The correct answer is **Linezolid**. To solve this question, one must categorize antimicrobial agents based on their primary mechanism of action: inhibition of cell wall synthesis, protein synthesis, or nucleic acid synthesis. **1. Why Linezolid is the correct answer:** Linezolid belongs to the **Oxazolidinone** class. Its primary mechanism is the **inhibition of protein synthesis**. Specifically, it binds to the 23S ribosomal RNA of the **50S subunit**, preventing the formation of the 70S initiation complex. Because it acts on protein translation rather than DNA/RNA replication or transcription, it does not inhibit nucleic acid synthesis. **2. Why the other options are incorrect:** * **Rifampicin:** Inhibits **DNA-dependent RNA polymerase**, thereby blocking the synthesis of mRNA (transcription). * **Fluoroquinolones (e.g., Ciprofloxacin):** Inhibit **DNA Gyrase (Topoisomerase II)** and **Topoisomerase IV**, preventing DNA replication and transcription. * **Nitrofurantoin:** This drug is reduced by bacterial flavoproteins to reactive intermediates that **damage bacterial DNA** and inhibit various enzymes involved in nucleic acid metabolism. **Clinical Pearls for NEET-PG:** * **Linezolid Spectrum:** It is a "reserve drug" primarily used for Gram-positive infections, including **MRSA** (Methicillin-resistant *Staph. aureus*) and **VRE** (Vancomycin-resistant *Enterococci*). * **Side Effects of Linezolid:** Long-term use can cause **thrombocytopenia** (bone marrow suppression) and **optic/peripheral neuropathy**. * **Drug Interaction:** Linezolid is a weak non-selective **MAO inhibitor**; it can cause **Serotonin Syndrome** if co-administered with SSRIs. * **Mnemonic for Protein Synthesis Inhibitors:** "**Buy AT 30, CELL at 50**" (Aminoglycosides, Tetracyclines act on 30S; Chloramphenicol, Erythromycin/Macrolides, Linezolid, Lincosamides act on 50S).

Q: Which anti-HIV drug combination should not be used?

All of the above. **Explanation:** The correct answer is **D (All of the above)** because these combinations result in either pharmacological antagonism or additive toxicities, making them clinically inappropriate. **1. Zidovudine (AZT) + Stavudine (d4T):** This is a classic example of **pharmacological antagonism**. Both drugs are thymidine analogs that require intracellular phosphorylation by the same enzyme, **thymidine kinase**, to become active. Zidovudine has a higher affinity for this enzyme and competitively inhibits the activation of Stavudine, rendering the combination ineffective. **2. Atazanavir + Indinavir:** Both are Protease Inhibitors (PIs). Combining them is avoided because they share a similar toxicity profile, specifically **hyperbilirubinemia** (indirect). Using them together significantly increases the risk of severe jaundice and nephrolithiasis without providing additional antiviral synergy. **3. Didanosine/Stavudine + Zalcitabine:** These combinations are contraindicated due to **overlapping toxicities**. All three are Nucleoside Reverse Transcriptase Inhibitors (NRTIs) that can cause severe **peripheral neuropathy** and **pancreatitis**. Furthermore, the combination of Stavudine and Didanosine is specifically linked to a high risk of fatal lactic acidosis, especially in pregnant women. **High-Yield Clinical Pearls for NEET-PG:** * **Mnemonic for Peripheral Neuropathy (NRTIs):** The "3 Ds" – Didanosine, Zalcitabine (ddC), and Stavudine (d4T). * **Zidovudine** is known for causing **bone marrow suppression** (anemia/neutropenia). * **Abacavir** is associated with hypersensitivity reactions linked to the **HLA-B*5701** allele. * **Tenofovir** is the NRTI most commonly associated with **renal toxicity** (Fanconi syndrome) and decreased bone mineral density [1].

Q: What is the most effective antitubercular drug against slow multiplying intracellular mycobacteria?

Pyrazinamide. ### Explanation The correct answer is **Pyrazinamide (Option C)**. #### Why Pyrazinamide is Correct Mycobacterium tuberculosis populations are heterogeneous. Pyrazinamide is uniquely effective against **slowly multiplying intracellular bacilli** located within the acidic environment of macrophages (phagosomes). * **Mechanism:** It is a prodrug converted by the bacterial enzyme **pyrazinamidase** into **pyrazinoic acid**. This conversion occurs most efficiently at an acidic pH. * **Sterilizing Action:** Because it targets the "persisters" (dormant bacilli) that other drugs cannot reach, it possesses the highest **sterilizing activity**. This unique property allowed the duration of TB treatment to be shortened from 9 months to 6 months. #### Why Other Options are Incorrect * **Rifampicin (Option A):** While it is a potent bactericidal drug, it is most effective against **spurters** (bacilli that undergo occasional bursts of metabolic activity). It is considered the best sterilizing agent overall but is not as specific for the acidic intracellular niche as Pyrazinamide. * **Isoniazid (Option B):** It is the most potent bactericidal drug against **rapidly multiplying extracellular bacilli** (found in the walls of cavitary lesions). It has poor activity against slow-growers. * **Ethambutol (Option D):** It is primarily **bacteriostatic** and is used to prevent the emergence of resistance to other drugs. It does not have significant sterilizing activity against dormant bacilli. #### NEET-PG High-Yield Pearls * **Site of Action:** Pyrazinamide = Acidic pH (Intracellular); Streptomycin = Alkaline pH (Extracellular). * **Toxicity:** Pyrazinamide is the **most hepatotoxic** of the first-line drugs and commonly causes **hyperuricemia** (due to inhibition of uric acid excretion), which may precipitate gout. * **Resistance:** Mutation in the **pncA gene** (encoding pyrazinamidase) is the most common cause of resistance.

Question 1

What is the drug of choice for malaria during pregnancy?

Accepted Answer

Chloroquine

Answer

Quinine

Answer

Primaquine

Answer

Mepacrine

Question 2

In the treatment of Hepatitis C, interferon is combined with which drug?

Accepted Answer

Ribavarin

Answer

Acyclovir

Answer

Lamivudine

Answer

Indinavir

Question 3

Penicillin is effective against which of the following organisms?

Accepted Answer

All of the above

Answer

Neisseria meningitidis

Answer

Neisseria gonorrhoeae

Answer

Treponema pallidum

Question 4

Tetracycline is a broad-spectrum antibiotic. What is the primary mechanism of resistance developed against this drug?

Accepted Answer

Efflux pump mechanism

Answer

Enzymatic inactivation of the drug

Answer

Alteration of the drug's binding site

Answer

Absence of a required metabolic pathway

Question 5

Which anti-tuberculosis drug is not toxic to the liver?

Accepted Answer

Streptomycin

Answer

Isoniazid

Answer

Rifampicin

Answer

Pyrazinamide

Question 6

Beta-lactamase production is a common mechanism of resistance in strains of H. influenzae, M. catarrhalis, and Neisseria gonorrhoeae. Which one of the following drugs is most likely to be effective against all strains of these organisms?

Accepted Answer

Ceftriaxone

Answer

Amoxicillin

Answer

Clindamycin

Answer

TMP-SMX

Question 7

Which drug can cause complete histopathological resolution in patients with hepatitis B?

Accepted Answer

Entecavir

Answer

Cyclosporin

Answer

Ribavirin

Answer

None of the above

Question 8

Which drug does NOT inhibit nucleic acid synthesis?

Accepted Answer

Linezolid

Answer

Rifampicin

Answer

Fluoroquinolone

Answer

Nitrofurantoin

Question 9

Which anti-HIV drug combination should not be used?

Accepted Answer

All of the above

Answer

Zidovudine + Stavudine

Answer

Atazanavir + Indinavir

Answer

Didanosine/stavudine + Zalcitabine

Question 10

What is the most effective antitubercular drug against slow multiplying intracellular mycobacteria?

Accepted Answer

Pyrazinamide

Answer

Rifampicin

Answer

Isoniazid

Answer

Ethambutol

Antimicrobial Agents — MCQs

Antimicrobial Agents — MCQs

On this page

Practice by Chapter

Want unlimited practice?